| 30.5689 0.894 (3.01%) | 10-05 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 35.95 |
1-year : | 41.99 |
| Resists | First : | 30.78 |
Second : | 35.95 |
| Pivot price | 29.44 |
|||
| Supports | First : | 28.13 |
Second : | 26.5 |
| MAs | MA(5) : | 29.96 |
MA(20) : | 29.04 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | 0.5 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 77.2 |
D(3) : | 77.5  |
| RSI | RSI(14): 64.8 |
|||
| 52-week | High : | 31.21 | Low : | 25 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ HLTH ] has closed below upper band by 6.9%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 30.82 - 30.93 | 30.93 - 31.02 |
| Low: | 29.35 - 29.49 | 29.49 - 29.6 |
| Close: | 30.35 - 30.58 | 30.58 - 30.75 |
Tema Healthcare AI ETF is an actively managed exchange-traded fund that focuses on the intersection of artificial intelligence and healthcare. It targets global life science, tech, and medical companies driving AI-integrated drug discovery, robotic surgery, and healthcare operational efficiencies.
Sat, 03 Oct 2026
Funds - Zacks Investment Research
Tue, 22 Sep 2026
The AI Drug Discovery Revolution - Tema ETFs
Tue, 25 Aug 2026
GENB Stock Price and Chart — NASDAQ:GENB - TradingView
Tue, 21 Jul 2026
How AI Is Poised to Transform Healthcare—And Why It Matters - Tema ETFs
Tue, 21 Jul 2026
Tema Launches Healthcare AI ETF (HLTH) - Tema ETFs
Mon, 20 Jul 2026
HLTH ETF Profile: Dividends, Returns (NASDAQ:HLTH) - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|